Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Medicinal Radiocompounds refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Medicinal Radiocompounds are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
Market Analysis and Insights: Global Medicinal Radiocompounds Market
Due to the COVID-19 pandemic, the global Medicinal Radiocompounds market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Technetium 99 accounting for % of the Medicinal Radiocompounds global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Oncology segment is altered to an % CAGR throughout this forecast period.
North America Medicinal Radiocompounds market is estimated at US$ million in 2021, while Europe is forecast to reach US$ million by 2028. The proportion of the North America is % in 2021, while Europe percentage is %, and it is predicted that Europe share will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. As for the Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The global major manufacturers of Medicinal Radiocompounds include Bracco Imaging, Bayer, Cardinal Health, Curium Pharma, Novartis, Lantheus, Acrotech Biopharma, GE Healthcare and China Isotope & Radiation, etc. In terms of revenue, the global 3 largest players have a % market share of Medicinal Radiocompounds in 2021.
Global Medicinal Radiocompounds Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2017 to 2028. This section mentions the volume of production by region from 2017 to 2028. Pricing analysis is included in the report according to each type from the year 2017 to 2028, manufacturer from 2017 to 2022, region from 2017 to 2022, and global price from 2017 to 2028.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Medicinal Radiocompounds Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Segment by Application
By Company
Production by Region
Index
1 Medicinal Radiocompounds Market Overview
1.1 Product Overview and Scope of Medicinal Radiocompounds
1.2 Medicinal Radiocompounds Segment by Type
1.2.1 Global Medicinal Radiocompounds Market Size Growth Rate Analysis by Type 2022 VS 2028
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Medicinal Radiocompounds Segment by Application
1.3.1 Global Medicinal Radiocompounds Consumption Comparison by Application: 2022 VS 2028
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Medicinal Radiocompounds Revenue Estimates and Forecasts (2017-2028)
1.4.2 Global Medicinal Radiocompounds Production Capacity Estimates and Forecasts (2017-2028)
1.4.3 Global Medicinal Radiocompounds Production Estimates and Forecasts (2017-2028)
1.5 Global Market Size by Region
1.5.1 Global Medicinal Radiocompounds Market Size Estimates and Forecasts by Region: 2017 VS 2021 VS 2028
1.5.2 North America Medicinal Radiocompounds Estimates and Forecasts (2017-2028)
1.5.3 Europe Medicinal Radiocompounds Estimates and Forecasts (2017-2028)
1.5.4 China Medicinal Radiocompounds Estimates and Forecasts (2017-2028)
1.5.5 Japan Medicinal Radiocompounds Estimates and Forecasts (2017-2028)
2 Market Competition by Manufacturers
2.1 Global Medicinal Radiocompounds Production Capacity Market Share by Manufacturers (2017-2022)
2.2 Global Medicinal Radiocompounds Revenue Market Share by Manufacturers (2017-2022)
2.3 Medicinal Radiocompounds Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Medicinal Radiocompounds Average Price by Manufacturers (2017-2022)
2.5 Manufacturers Medicinal Radiocompounds Production Sites, Area Served, Product Types
2.6 Medicinal Radiocompounds Market Competitive Situation and Trends
2.6.1 Medicinal Radiocompounds Market Concentration Rate
2.6.2 Global 5 and 10 Largest Medicinal Radiocompounds Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
3.1 Global Production Capacity of Medicinal Radiocompounds Market Share by Region (2017-2022)
3.2 Global Medicinal Radiocompounds Revenue Market Share by Region (2017-2022)
3.3 Global Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.4 North America Medicinal Radiocompounds Production
3.4.1 North America Medicinal Radiocompounds Production Growth Rate (2017-2022)
3.4.2 North America Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.5 Europe Medicinal Radiocompounds Production
3.5.1 Europe Medicinal Radiocompounds Production Growth Rate (2017-2022)
3.5.2 Europe Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.6 China Medicinal Radiocompounds Production
3.6.1 China Medicinal Radiocompounds Production Growth Rate (2017-2022)
3.6.2 China Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.7 Japan Medicinal Radiocompounds Production
3.7.1 Japan Medicinal Radiocompounds Production Growth Rate (2017-2022)
3.7.2 Japan Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
4 Global Medicinal Radiocompounds Consumption by Region
4.1 Global Medicinal Radiocompounds Consumption by Region
4.1.1 Global Medicinal Radiocompounds Consumption by Region
4.1.2 Global Medicinal Radiocompounds Consumption Market Share by Region
4.2 North America
4.2.1 North America Medicinal Radiocompounds Consumption by Country
4.2.2 United States
4.2.3 Canada
4.3 Europe
4.3.1 Europe Medicinal Radiocompounds Consumption by Country
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Medicinal Radiocompounds Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 China Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Medicinal Radiocompounds Consumption by Country
4.5.2 Mexico
4.5.3 Brazil
5 Segment by Type
5.1 Global Medicinal Radiocompounds Production Market Share by Type (2017-2022)
5.2 Global Medicinal Radiocompounds Revenue Market Share by Type (2017-2022)
5.3 Global Medicinal Radiocompounds Price by Type (2017-2022)
6 Segment by Application
6.1 Global Medicinal Radiocompounds Production Market Share by Application (2017-2022)
6.2 Global Medicinal Radiocompounds Revenue Market Share by Application (2017-2022)
6.3 Global Medicinal Radiocompounds Price by Application (2017-2022)
7 Key Companies Profiled
7.1 Bracco Imaging
7.1.1 Bracco Imaging Medicinal Radiocompounds Corporation Information
7.1.2 Bracco Imaging Medicinal Radiocompounds Product Portfolio
7.1.3 Bracco Imaging Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.1.4 Bracco Imaging Main Business and Markets Served
7.1.5 Bracco Imaging Recent Developments/Updates
7.2 Bayer
7.2.1 Bayer Medicinal Radiocompounds Corporation Information
7.2.2 Bayer Medicinal Radiocompounds Product Portfolio
7.2.3 Bayer Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.2.4 Bayer Main Business and Markets Served
7.2.5 Bayer Recent Developments/Updates
7.3 Cardinal Health
7.3.1 Cardinal Health Medicinal Radiocompounds Corporation Information
7.3.2 Cardinal Health Medicinal Radiocompounds Product Portfolio
7.3.3 Cardinal Health Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.3.4 Cardinal Health Main Business and Markets Served
7.3.5 Cardinal Health Recent Developments/Updates
7.4 Curium Pharma
7.4.1 Curium Pharma Medicinal Radiocompounds Corporation Information
7.4.2 Curium Pharma Medicinal Radiocompounds Product Portfolio
7.4.3 Curium Pharma Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.4.4 Curium Pharma Main Business and Markets Served
7.4.5 Curium Pharma Recent Developments/Updates
7.5 Novartis
7.5.1 Novartis Medicinal Radiocompounds Corporation Information
7.5.2 Novartis Medicinal Radiocompounds Product Portfolio
7.5.3 Novartis Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.5.4 Novartis Main Business and Markets Served
7.5.5 Novartis Recent Developments/Updates
7.6 Lantheus
7.6.1 Lantheus Medicinal Radiocompounds Corporation Information
7.6.2 Lantheus Medicinal Radiocompounds Product Portfolio
7.6.3 Lantheus Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.6.4 Lantheus Main Business and Markets Served
7.6.5 Lantheus Recent Developments/Updates
7.7 Acrotech Biopharma
7.7.1 Acrotech Biopharma Medicinal Radiocompounds Corporation Information
7.7.2 Acrotech Biopharma Medicinal Radiocompounds Product Portfolio
7.7.3 Acrotech Biopharma Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.7.4 Acrotech Biopharma Main Business and Markets Served
7.7.5 Acrotech Biopharma Recent Developments/Updates
7.8 GE Healthcare
7.8.1 GE Healthcare Medicinal Radiocompounds Corporation Information
7.8.2 GE Healthcare Medicinal Radiocompounds Product Portfolio
7.8.3 GE Healthcare Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.8.4 GE Healthcare Main Business and Markets Served
7.7.5 GE Healthcare Recent Developments/Updates
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Medicinal Radiocompounds Corporation Information
7.9.2 China Isotope & Radiation Medicinal Radiocompounds Product Portfolio
7.9.3 China Isotope & Radiation Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.9.4 China Isotope & Radiation Main Business and Markets Served
7.9.5 China Isotope & Radiation Recent Developments/Updates
7.10 Jubilant Pharma
7.10.1 Jubilant Pharma Medicinal Radiocompounds Corporation Information
7.10.2 Jubilant Pharma Medicinal Radiocompounds Product Portfolio
7.10.3 Jubilant Pharma Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.10.4 Jubilant Pharma Main Business and Markets Served
7.10.5 Jubilant Pharma Recent Developments/Updates
7.11 Eli Lilly
7.11.1 Eli Lilly Medicinal Radiocompounds Corporation Information
7.11.2 Eli Lilly Medicinal Radiocompounds Product Portfolio
7.11.3 Eli Lilly Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.11.4 Eli Lilly Main Business and Markets Served
7.11.5 Eli Lilly Recent Developments/Updates
7.12 SIEMENS
7.12.1 SIEMENS Medicinal Radiocompounds Corporation Information
7.12.2 SIEMENS Medicinal Radiocompounds Product Portfolio
7.12.3 SIEMENS Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.12.4 SIEMENS Main Business and Markets Served
7.12.5 SIEMENS Recent Developments/Updates
7.13 Dongcheng
7.13.1 Dongcheng Medicinal Radiocompounds Corporation Information
7.13.2 Dongcheng Medicinal Radiocompounds Product Portfolio
7.13.3 Dongcheng Medicinal Radiocompounds Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.13.4 Dongcheng Main Business and Markets Served
7.13.5 Dongcheng Recent Developments/Updates
8 Medicinal Radiocompounds Manufacturing Cost Analysis
8.1 Medicinal Radiocompounds Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Medicinal Radiocompounds
8.4 Medicinal Radiocompounds Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Medicinal Radiocompounds Distributors List
9.3 Medicinal Radiocompounds Customers
10 Market Dynamics
10.1 Medicinal Radiocompounds Industry Trends
10.2 Medicinal Radiocompounds Market Drivers
10.3 Medicinal Radiocompounds Market Challenges
10.4 Medicinal Radiocompounds Market Restraints
11 Production and Supply Forecast
11.1 Global Forecasted Production of Medicinal Radiocompounds by Region (2023-2028)
11.2 North America Medicinal Radiocompounds Production, Revenue Forecast (2023-2028)
11.3 Europe Medicinal Radiocompounds Production, Revenue Forecast (2023-2028)
11.4 China Medicinal Radiocompounds Production, Revenue Forecast (2023-2028)
11.5 Japan Medicinal Radiocompounds Production, Revenue Forecast (2023-2028)
12 Consumption and Demand Forecast
12.1 Global Forecasted Demand Analysis of Medicinal Radiocompounds
12.2 North America Forecasted Consumption of Medicinal Radiocompounds by Country
12.3 Europe Market Forecasted Consumption of Medicinal Radiocompounds by Country
12.4 Asia Pacific Market Forecasted Consumption of Medicinal Radiocompounds by Region
12.5 Latin America Forecasted Consumption of Medicinal Radiocompounds by Country
13 Forecast by Type and by Application (2023-2028)
13.1 Global Production, Revenue and Price Forecast by Type (2023-2028)
13.1.1 Global Forecasted Production of Medicinal Radiocompounds by Type (2023-2028)
13.1.2 Global Forecasted Revenue of Medicinal Radiocompounds by Type (2023-2028)
13.1.3 Global Forecasted Price of Medicinal Radiocompounds by Type (2023-2028)
13.2 Global Forecasted Consumption of Medicinal Radiocompounds by Application (2023-2028)
13.2.1 Global Forecasted Production of Medicinal Radiocompounds by Application (2023-2028)
13.2.2 Global Forecasted Revenue of Medicinal Radiocompounds by Application (2023-2028)
13.2.3 Global Forecasted Price of Medicinal Radiocompounds by Application (2023-2028)
14 Research Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Medicinal Radiocompounds Market Size by Type (Tons) & (US$ Million) (2022 VS 2028)
Table 2. Global Medicinal Radiocompounds Market Size by Application (Tons) & (US$ Million) (2022 VS 2028)
Table 3. Medicinal Radiocompounds Market Size Comparison by Region: 2017 VS 2021 VS 2028
Table 4. Global Medicinal Radiocompounds Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 5. Global Medicinal Radiocompounds Production (Tons) by Manufacturers (2017-2022)
Table 6. Global Medicinal Radiocompounds Production Market Share by Manufacturers (2017-2022)
Table 7. Global Medicinal Radiocompounds Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 8. Global Medicinal Radiocompounds Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Medicinal Radiocompounds as of 2021)
Table 10. Global Market Medicinal Radiocompounds Average Price (US$/Ton) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Medicinal Radiocompounds Production Sites and Area Served
Table 12. Manufacturers Medicinal Radiocompounds Product Types
Table 13. Global Medicinal Radiocompounds Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Medicinal Radiocompounds Production Capacity (Tons) by Region (2017-2022)
Table 16. Global Medicinal Radiocompounds Production (Tons) by Region (2017-2022)
Table 17. Global Medicinal Radiocompounds Revenue (US$ Million) by Region (2017-2022)
Table 18. Global Medicinal Radiocompounds Revenue Market Share by Region (2017-2022)
Table 19. Global Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 20. North America Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 21. Europe Medicinal Radiocompounds Production (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 22. China Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 23. Japan Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 24. Global Medicinal Radiocompounds Consumption Market by Region (2017-2022) & (Tons)
Table 25. Global Medicinal Radiocompounds Consumption Market Share by Region (2017-2022)
Table 26. North America Medicinal Radiocompounds Consumption by Country (2017-2022) & (Tons)
Table 27. Europe Medicinal Radiocompounds Consumption by Country (2017-2022) & (Tons)
Table 28. Asia Pacific Medicinal Radiocompounds Consumption by Region (2017-2022) & (Tons)
Table 29. Latin America Medicinal Radiocompounds Consumption by Country (2017-2022) & (Tons)
Table 30. Global Medicinal Radiocompounds Production (Tons) by Type (2017-2022)
Table 31. Global Medicinal Radiocompounds Production Market Share by Type (2017-2022)
Table 32. Global Medicinal Radiocompounds Revenue (US$ Million) by Type (2017-2022)
Table 33. Global Medicinal Radiocompounds Revenue Share by Type (2017-2022)
Table 34. Global Medicinal Radiocompounds Price (US$/Ton) by Type (2017-2022)
Table 35. Global Medicinal Radiocompounds Production by Application (2017-2022) & (Tons)
Table 36. Global Medicinal Radiocompounds Production Market Share by Application (2017-2022)
Table 37. Global Medicinal Radiocompounds Revenue (US$ Million) by Application (2017-2022)
Table 38. Global Medicinal Radiocompounds Revenue Share by Application (2017-2022)
Table 39. Global Medicinal Radiocompounds Price (US$/Ton) by Application (2017-2022)
Table 40. Bracco Imaging Medicinal Radiocompounds Corporation Information
Table 41. Bracco Imaging Specification and Application
Table 42. Bracco Imaging Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 43. Bracco Imaging Main Business and Markets Served
Table 44. Bracco Imaging Recent Developments/Updates
Table 45. Bayer Medicinal Radiocompounds Corporation Information
Table 46. Bayer Specification and Application
Table 47. Bayer Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 48. Bayer Main Business and Markets Served
Table 49. Bayer Recent Developments/Updates
Table 50. Cardinal Health Medicinal Radiocompounds Corporation Information
Table 51. Cardinal Health Specification and Application
Table 52. Cardinal Health Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 53. Cardinal Health Main Business and Markets Served
Table 54. Cardinal Health Recent Developments/Updates
Table 55. Curium Pharma Medicinal Radiocompounds Corporation Information
Table 56. Curium Pharma Specification and Application
Table 57. Curium Pharma Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 58. Curium Pharma Main Business and Markets Served
Table 59. Curium Pharma Recent Developments/Updates
Table 60. Novartis Medicinal Radiocompounds Corporation Information
Table 61. Novartis Specification and Application
Table 62. Novartis Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 63. Novartis Main Business and Markets Served
Table 64. Novartis Recent Developments/Updates
Table 65. Lantheus Medicinal Radiocompounds Corporation Information
Table 66. Lantheus Specification and Application
Table 67. Lantheus Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 68. Lantheus Main Business and Markets Served
Table 69. Lantheus Recent Developments/Updates
Table 70. Acrotech Biopharma Medicinal Radiocompounds Corporation Information
Table 71. Acrotech Biopharma Specification and Application
Table 72. Acrotech Biopharma Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 73. Acrotech Biopharma Main Business and Markets Served
Table 74. Acrotech Biopharma Recent Developments/Updates
Table 75. GE Healthcare Medicinal Radiocompounds Corporation Information
Table 76. GE Healthcare Specification and Application
Table 77. GE Healthcare Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 78. GE Healthcare Main Business and Markets Served
Table 79. GE Healthcare Recent Developments/Updates
Table 80. China Isotope & Radiation Medicinal Radiocompounds Corporation Information
Table 81. China Isotope & Radiation Specification and Application
Table 82. China Isotope & Radiation Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 83. China Isotope & Radiation Main Business and Markets Served
Table 84. China Isotope & Radiation Recent Developments/Updates
Table 85. Jubilant Pharma Medicinal Radiocompounds Corporation Information
Table 86. Jubilant Pharma Specification and Application
Table 87. Jubilant Pharma Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 88. Jubilant Pharma Main Business and Markets Served
Table 89. Jubilant Pharma Recent Developments/Updates
Table 90. Eli Lilly Medicinal Radiocompounds Corporation Information
Table 91. Eli Lilly Specification and Application
Table 92. Eli Lilly Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 93. Eli Lilly Main Business and Markets Served
Table 94. Eli Lilly Recent Developments/Updates
Table 95. SIEMENS Medicinal Radiocompounds Corporation Information
Table 96. SIEMENS Specification and Application
Table 97. SIEMENS Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 98. SIEMENS Main Business and Markets Served
Table 99. SIEMENS Recent Developments/Updates
Table 100. Dongcheng Medicinal Radiocompounds Corporation Information
Table 101. Dongcheng Specification and Application
Table 102. Dongcheng Medicinal Radiocompounds Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 103. Dongcheng Main Business and Markets Served
Table 104. Dongcheng Recent Developments/Updates
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Medicinal Radiocompounds Distributors List
Table 108. Medicinal Radiocompounds Customers List
Table 109. Medicinal Radiocompounds Market Trends
Table 110. Medicinal Radiocompounds Market Drivers
Table 111. Medicinal Radiocompounds Market Challenges
Table 112. Medicinal Radiocompounds Market Restraints
Table 113. Global Medicinal Radiocompounds Production (Tons) Forecast by Region (2023-2028)
Table 114. North America Medicinal Radiocompounds Consumption Forecast by Country (2023-2028) & (Tons)
Table 115. Europe Medicinal Radiocompounds Consumption Forecast by Country (2023-2028) & (Tons)
Table 116. Asia Pacific Medicinal Radiocompounds Consumption Forecast by Region (2023-2028) & (Tons)
Table 117. Latin America Medicinal Radiocompounds Consumption Forecast by Country (2023-2028) & (Tons)
Table 118. Global Medicinal Radiocompounds Production Forecast by Type (2023-2028) & (Tons)
Table 119. Global Medicinal Radiocompounds Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 120. Global Medicinal Radiocompounds Price Forecast by Type (2023-2028) & (US$/Ton)
Table 121. Global Medicinal Radiocompounds Production Forecast by Application (2023-2028) & (Tons)
Table 122. Global Medicinal Radiocompounds Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 123. Global Medicinal Radiocompounds Price Forecast by Application (2023-2028) & (US$/Ton)
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Medicinal Radiocompounds
Figure 2. Global Medicinal Radiocompounds Market Share by Type: 2022 VS 2028
Figure 3. Technetium 99 Product Picture
Figure 4. Fluorine 18 Product Picture
Figure 5. Other Product Picture
Figure 6. Global Medicinal Radiocompounds Market Share by Application: 2022 VS 2028
Figure 7. Oncology
Figure 8. Cardiology
Figure 9. Others
Figure 10. Global Medicinal Radiocompounds Revenue (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Medicinal Radiocompounds Revenue (US$ Million) (2017-2028)
Figure 12. Global Medicinal Radiocompounds Production Capacity (Tons) & (2017-2028)
Figure 13. Global Medicinal Radiocompounds Production (Tons) & (2017-2028)
Figure 14. North America Medicinal Radiocompounds Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 15. Europe Medicinal Radiocompounds Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 16. China Medicinal Radiocompounds Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 17. Japan Medicinal Radiocompounds Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 18. Medicinal Radiocompounds Production Share by Manufacturers in 2021
Figure 19. Global Medicinal Radiocompounds Revenue Share by Manufacturers in 2021
Figure 20. Medicinal Radiocompounds Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Market Medicinal Radiocompounds Average Price (US$/Ton) of Key Manufacturers in 2021
Figure 22. The Global 5 and 10 Largest Players: Market Share by Medicinal Radiocompounds Revenue in 2021
Figure 23. Global Medicinal Radiocompounds Production Market Share by Region (2017-2022)
Figure 24. North America Medicinal Radiocompounds Production (Tons) Growth Rate (2017-2022)
Figure 25. Europe Medicinal Radiocompounds Production (Tons) Growth Rate (2017-2022)
Figure 26. China Medicinal Radiocompounds Production (Tons) Growth Rate (2017-2022)
Figure 27. Japan Medicinal Radiocompounds Production (Tons) Growth Rate (2017-2022)
Figure 28. Global Medicinal Radiocompounds Consumption Market Share by Region (2017-2022)
Figure 29. North America Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 30. North America Medicinal Radiocompounds Consumption Market Share by Country in 2021
Figure 31. Canada Medicinal Radiocompounds Consumption Growth Rate (2017-2022) & (Tons)
Figure 32. U.S. Medicinal Radiocompounds Consumption Growth Rate (2017-2022) & (Tons)
Figure 33. Europe Medicinal Radiocompounds Consumption Growth Rate (2017-2022) & (Tons)
Figure 34. Europe Medicinal Radiocompounds Consumption Market Share by Country in 2021
Figure 35. Germany Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 36. France Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 37. U.K. Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 38. Italy Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 39. Russia Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 40. Asia Pacific Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 41. Asia Pacific Medicinal Radiocompounds Consumption Market Share by Regions in 2021
Figure 42. China Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 43. Japan Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 44. South Korea Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 45. China Taiwan Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 46. Southeast Asia Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 47. India Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 48. Australia Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 49. Latin America Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 50. Latin America Medicinal Radiocompounds Consumption Market Share by Country in 2021
Figure 51. Mexico Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 52. Brazil Medicinal Radiocompounds Consumption and Growth Rate (2017-2022) & (Tons)
Figure 53. Production Market Share of Medicinal Radiocompounds by Type (2017-2022)
Figure 54. Production Market Share of Medicinal Radiocompounds by Type in 2021
Figure 55. Revenue Share of Medicinal Radiocompounds by Type (2017-2022)
Figure 56. Revenue Market Share of Medicinal Radiocompounds by Type in 2021
Figure 57. Production Market Share of Medicinal Radiocompounds by Application (2017-2022)
Figure 58. Production Market Share of Medicinal Radiocompounds by Application in 2021
Figure 59. Revenue Share of Medicinal Radiocompounds by Application (2017-2022)
Figure 60. Revenue Market Share of Medicinal Radiocompounds by Application in 2021
Figure 61. Manufacturing Cost Structure of Medicinal Radiocompounds
Figure 62. Manufacturing Process Analysis of Medicinal Radiocompounds
Figure 63. Medicinal Radiocompounds Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Global Medicinal Radiocompounds Production Market Share Forecast by Region (2023-2028)
Figure 67. North America Medicinal Radiocompounds Production (Tons) Growth Rate Forecast (2023-2028)
Figure 68. Europe Medicinal Radiocompounds Production (Tons) Growth Rate Forecast (2023-2028)
Figure 69. China Medicinal Radiocompounds Production (Tons) Growth Rate Forecast (2023-2028)
Figure 70. Japan Medicinal Radiocompounds Production (Tons) Growth Rate Forecast (2023-2028)
Figure 71. Global Forecasted Demand Analysis of Medicinal Radiocompounds (2017-2028) & (Tons)
Figure 72. Global Medicinal Radiocompounds Production Market Share Forecast by Type (2023-2028)
Figure 73. Global Medicinal Radiocompounds Revenue Market Share Forecast by Type (2023-2028)
Figure 74. Global Medicinal Radiocompounds Production Market Share Forecast by Application (2023-2028)
Figure 75. Global Medicinal Radiocompounds Revenue Market Share Forecast by Application (2023-2028)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Published By : QY Research